SCHEMBL16731946

SCHEMBL16731946

O=C(OC(=O)c1ccc2c(c1)C(=O)c1cc(C(=O)OC(=O)c3ccccc3)ccc1-2)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 2/20 0.58
▸ PTPRC P08575 3/20 0.56
▸ MAPT P10636 6/20 0.55
▸ NPC1 O15118 3/20 0.55
▸ LMNA P02545 3/20 0.55
▸ RAB9A P51151 3/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ ALDH1A1 P00352 2/20 0.55
▸ HTR7 P34969 1/20 0.47
▸ HTR2B P41595 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ S100A4 P26447 1/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ CTSL P07711 1/20 0.45
▸ PTPN13 Q12923 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ F2 P00734 1/20 0.45
▸ ACE2 Q9BYF1 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16731600 0.92 S100A4 (0.59) TTRPTPRCMAPTNPC1LMNA
SCHEMBL6934221 0.91 TTR (0.65) TTRPTPRCMAPTNPC1LMNA
SCHEMBL6933741 0.89 TTR (0.67) TTRPTPRCMAPTNPC1LMNA
SCHEMBL8717537 0.80 LMNA (0.67) MAPTLMNASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL13849150 0.79 TTR (0.63) TTRPTPRCMAPTNPC1LMNA
SCHEMBL11579212 0.79 TTR (0.63) TTRPTPRCMAPTNPC1LMNA
SCHEMBL545343 0.78 LMNA (0.58) MAPTLMNARAB9ASMN1; SMN2ALDH1A1
Hydrogen Peroxide SCHEMBL27952375 0.78 LMNA (0.70) MAPTLMNASMN1; SMN2ALDH1A1L3MBTL1
Benzene SCHEMBL27793442 0.78 LMNA (0.70) MAPTLMNASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL52413 0.78 LMNA (0.70) MAPTLMNASMN1; SMN2ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210388161-A1 METHOD OF MAKING RELEASABLE POLYMERIC REAGENTS NEKTAR THERAPEUTICS 2021-12-16 — — US disclosed
US-20200276320-A1 COMPOSITION COMPRISING A POLYMERIC REAGENT NEKTAR THERAPEUTICS (US) 2020-09-03 — — US disclosed
US-20150141665-A1 METHODS FOR PREPARING POLYMERIC REAGENTS NEKTAR THERAPEUTICS (US) 2015-05-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200276320-A1 COMPOSITION COMPRISING A POLYMERIC REAGENT CD44, FCGRT, C9 TTR 774/4885PTPRC 553/4885MAPT 1479/4885
US-20150141665-A1 METHODS FOR PREPARING POLYMERIC REAGENTS PAM, ALKBH3, DNPEP TTR 1127/4885PTPRC 1029/4885MAPT 3976/4885
US-20210388161-A1 METHOD OF MAKING RELEASABLE POLYMERIC REAGENTS FGB, PCBP1, PFAS TTR 875/4885PTPRC 364/4885MAPT 2710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback